Literature DB >> 33297870

Slope of electrically evoked compound action potential amplitude growth function is site-dependent.

Oliver C Dziemba1, Aristotelis Aristeidou1, Stefan Brill2.   

Abstract

OBJECTIVES: In human cochlear implant (CI) recipients, the slope of the electrically evoked compound action potential (ECAP) amplitude growth function (AGF) is not very well investigated, in comparison to the threshold derived from the AGF. This is despite the fact that it was shown in animal experiments that the slope correlates with the number of excitable neurons. The rationale of this study was to establish baseline data of the AGF slope for possible clinical applications, while investigating stability over time and dependence on cochlear site.
DESIGN: ECAP AGFs of 16 ears implanted with MED-EL CIs were recorded on all electrode contacts during the normal clinical routine at 4 different points in time.
RESULTS: Due to patient availability, not all 16 ears could be measured at all 4 points in time. A dependence of the slope on the electrode position was visible and statistically significant: At the three electrode contacts at the apical end of the array, the slope is greater compared to the medial and basal region of the cochlea.
CONCLUSION: The three most apical electrode contacts show greater slopes of ECAP AGF recordings. Our data of the cohort slopes show mild effects between the 4 different points in time.

Entities:  

Keywords:  Amplitude Growth Function; Cochlear Implant; ECAP; Longitudinal; Slope

Year:  2020        PMID: 33297870     DOI: 10.1080/14670100.2020.1853956

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  1 in total

1.  Correlation of Electrically Evoked Compound Action Potential Amplitude Growth Function Slope and Anamnestic Parameters in Cochlear Implant Patients-Identification of Predictors for the Neuronal Health Status.

Authors:  Lutz Gärtner; Katharina Klötzer; Thomas Lenarz; Verena Scheper
Journal:  Life (Basel)       Date:  2021-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.